BERLIN (Reuters) - German biotech company Evotec said on Monday it had received a grant from the Bill & Melinda Gates Foundation to help identify and develop potential monoclonal antibody (mAbS) drugs for the prevention of severe COVID-19.
Several drugmakers are testing antibody treatments for COVID-19 to help patients' immune systems fight the coronavirus that causes the disease which has killed more than 1 million people worldwide.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!